Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Future Med Chem ; 14(3): 187-201, 2022 01.
Article in English | MEDLINE | ID: mdl-35100004

ABSTRACT

Ubiquitylation is a posttranslational modification of proteins that is necessary for a variety of cellular processes. E1 ubiquitin activating enzyme, E2 ubiquitin conjugating enzyme, and E3 ubiquitin ligase are all involved in transferring ubiquitin to the target substrate to regulate cellular function. The objective of this review is to provide an overview of different aspects of E3 ubiquitin ligases that can lead to major biological system failure in several deadly diseases. The first part of this review covers the important characteristics of E3 ubiquitin ligases and their classification based on structural domains. Further, the authors provide some online resources that help researchers explore the data relevant to the enzyme. The following section delves into the involvement of E3 ubiquitin ligases in various diseases and biological processes, including different types of cancer and neurological disorders.


Subject(s)
Enzyme Inhibitors/pharmacology , Neoplasms/drug therapy , Nervous System Diseases/drug therapy , Ubiquitin-Protein Ligases/antagonists & inhibitors , Enzyme Inhibitors/chemistry , Humans , Neoplasms/metabolism , Nervous System Diseases/metabolism , Ubiquitin-Protein Ligases/metabolism
2.
Mol Biotechnol ; 64(4): 355-372, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34741732

ABSTRACT

The CRISPR-Cas genome editing system is an intrinsic property of a bacteria-based immune system. This employs a guide RNA to detect and cleave the PAM-associated target DNA or RNA in subsequent infections, by the invasion of a similar bacteriophage. The discovery of Cas systems has paved the way to overcome the limitations of existing genome editing tools. In this review, we focus on Cas proteins that are available for gene modifications among which Cas9, Cas12a, and Cas13 have been widely used in the areas of medicine, research, and diagnostics. Since CRISPR has been already proven for its potential research applications, the next milestone for CRISPR will be proving its efficacy and safety. In this connection, we systematically review recent advances in exploring multiple variants of Cas proteins and their modifications for therapeutic applications.


Subject(s)
CRISPR-Cas Systems , Gene Editing , DNA/metabolism , RNA , RNA, Guide, Kinetoplastida/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...